Velorum Therapeutics
Breakthrough medicines unlocking the biology of heme
Y CombinatorWinter 2024ActiveHealthcareTherapeuticsBiotechHealthcareTherapeuticsDrug discovery
What they do
Problem
Diseases driven by heme biology lack effective targeted treatments.
Solution
Velorum Therapeutics develops breakthrough medicines by unlocking and targeting the biology of heme.
Who it's for
Patients with heme-related diseases (via prescribing physicians and healthcare systems).
Founders
Pouya Modareszadeh
Founder
Co-Founder & CEO @ Velorum Therapeutics. Building new medicines.
Parsa Modareszadeh
Founder
Co-Founder and President @ Velorum Therapeutics. Goldwater Scholar. Working to create breakthrough medicines for devastating diseases.
Company timeline
- Founded2023
- YC batchWinter 2024
- StatusActive
- Team size5 people
- LocationSan Francisco, CA, USA
Similar startups
BridgeBio
BridgeBio develops breakthrough medicines for genetic diseases. Its p…
Erasca
Fuck cancer. Every year in the United States, nearly 1.75 million new…
SFA Therapeutics
Regulating the immune system to block cancer & autoimmune diseases
Pharming Group
Pharming GroupA global biopharmaceutical company developing and comme…
Altay Therapeutics
Altay develops disease-modifying therapies targeting transcription…
IDRx
HIV ravaged entire communities before antiretroviral cocktail therapi…